Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes - Radioactive & Nonradioactive

Synthesis and preclinical evaluation of 11C-labeled (6-aryl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors

Jiyun SUN, Zhen Chen, Jiahui Chen, Hualong Fu, Tuo Shao, Lu WANG, Hao Xu, Ming-Rong Zhang and Steven Liang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 616;
Jiyun SUN
1Harvard Medical School and Mass General Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhen Chen
1Harvard Medical School and Mass General Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiahui Chen
1Harvard Medical School and Mass General Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hualong Fu
1Harvard Medical School and Mass General Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tuo Shao
1Harvard Medical School and Mass General Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lu WANG
1Harvard Medical School and Mass General Hospital Boston MA United States
2Jinan University, First affiliated Hospital, PET center Guangzhou China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hao Xu
2Jinan University, First affiliated Hospital, PET center Guangzhou China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ming-Rong Zhang
3Department of Radiopharmaceutis Development National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Steven Liang
1Harvard Medical School and Mass General Hospital Boston MA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 61 no. supplement 1 616

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 15, 2020.

Copyright & Usage 
© 2020

Author Information

  1. Jiyun SUN1,
  2. Zhen Chen1,
  3. Jiahui Chen1,
  4. Hualong Fu1,
  5. Tuo Shao1,
  6. Lu WANG1,2,
  7. Hao Xu2,
  8. Ming-Rong Zhang3 and
  9. Steven Liang1
  1. 1Harvard Medical School and Mass General Hospital Boston MA United States
  2. 2Jinan University, First affiliated Hospital, PET center Guangzhou China
  3. 3Department of Radiopharmaceutis Development National Institute of Radiological Sciences Chiba Japan

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2020 to April 2025

AbstractFullPdf
May 20203900
Jun 20205000
Jul 20203000
Aug 20201800
Sep 20201900
Oct 20201400
Nov 20202400
Dec 20201800
Jan 20211300
Feb 20211400
Mar 20211700
Apr 20211600
May 20211800
Jun 2021600
Jul 20211100
Aug 20211200
Sep 2021600
Oct 2021600
Nov 2021800
Dec 2021700
Jan 2022600
Feb 2022700
Mar 2022700
Apr 20221000
May 20221400
Jun 2022500
Jul 2022700
Aug 20221100
Sep 2022300
Oct 2022600
Nov 2022700
Dec 2022500
Jan 2023900
Feb 2023900
Mar 2023600
Apr 2023500
May 2023200
Jun 2023300
Jul 2023300
Aug 2023100
Sep 2023400
Oct 2023300
Nov 2023800
Dec 2023700
Jan 2024400
Feb 2024500
Mar 2024400
Apr 2024300
May 2024300
Jun 2024500
Jul 2024400
Aug 2024900
Sep 2024400
Oct 2024400
Nov 2024600
Dec 2024200
Feb 2025300
Mar 2025200
Apr 20251800
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Synthesis and preclinical evaluation of 11C-labeled (6-aryl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Synthesis and preclinical evaluation of 11C-labeled (6-aryl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors
Jiyun SUN, Zhen Chen, Jiahui Chen, Hualong Fu, Tuo Shao, Lu WANG, Hao Xu, Ming-Rong Zhang, Steven Liang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 616;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Synthesis and preclinical evaluation of 11C-labeled (6-aryl-1H-pyrrolo[3,2-b]pyridin-1-yl)acetamide for imaging GluN2B subunit of NMDA receptors
Jiyun SUN, Zhen Chen, Jiahui Chen, Hualong Fu, Tuo Shao, Lu WANG, Hao Xu, Ming-Rong Zhang, Steven Liang
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 616;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Targeting Probes - Radioactive & Nonradioactive

  • SPECT and PET imaging of CD11b-positive immune cells in an orthotopic mouse model of glioma with Zr-89 and Lu-177 labeled Lumi804-anti-CD11b antibody
  • ‘In-loop’ [11C]CO2fixation: Application to the synthesis of a 11C-labeled cholesterol 24-hydroxylase inhibitor
  • N-(Maleimidoethyl)-3-(guanidinomethyl)-5-[131I]iodobenzmide ([131I]MEGMIB): A Residualizing Prosthetic Agent for Site-Specific Radioiodination of Internalizing Single Domain Antibody Fragments.
Show more Molecular Targeting Probes - Radioactive & Nonradioactive

New Radiotracers

  • Syntheses of [11C]2- and [11C]3-trifluoromethyl-4-aminopyridine: potential PET radioligands for imaging demyelinating diseases
  • In vitro response of 177Lu-PSMA-617 with two different specific activities
Show more New Radiotracers

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire